tiprankstipranks
Cardiol Therapeutics Raises $15.5 Million in Offering
Company Announcements

Cardiol Therapeutics Raises $15.5 Million in Offering

Story Highlights

Cardiol Therapeutics (TSE:CRDL) has released an update.

Don't Miss our Black Friday Offers:

Cardiol Therapeutics has successfully completed a public offering, raising $15.525 million with the help of Canaccord Genuity as the sole bookrunner. The additional funds, garnered from the full exercise of an over-allotment option, will be directed to support clinical trials for CardiolRx, aimed at treating recurrent pericarditis, and other company expenses.

For further insights into TSE:CRDL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskCardiol Therapeutics Reports Promising Phase II Results
TipRanks Auto-Generated NewsdeskCardiol Therapeutics Faces Rising Losses and Falling Assets
TheFlyCardiol Therapeutics added to PRISM Emerging Biotech Index
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App